Market research

Pet Diagnostic Imaging Market

Explore licenses

Assess the study’s coverageRead the public overview, then compare the chapter outline with your research brief.

16report chapters

360iResearch introduction

Public research overview

Pet Diagnostic Imaging: Executive Summary

Pet diagnostic imaging encompasses radiography, ultrasound, computed tomography, magnetic resonance imaging, and related image-guided procedures used in veterinary assessment. Demand is shaped by companion-animal ownership, rising expectations for advanced care, specialty-veterinary capacity, clinician training, equipment access, and the need for faster, more definitive diagnoses. The market spans primary practices, referral hospitals, emergency facilities, veterinary teaching institutions, and mobile or outsourced imaging services.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to see every subchapter in context.

  1. Chapter 7 Imaging Modality

    • Radiography Systems
    • Ultrasound Systems
    • Computed Tomography Systems
    • Magnetic Resonance Imaging Systems
    More in this chapter
  2. Chapter 8 Animal Type

    • Cats
    • Dogs
    • Equine
    • Laboratory Animals
    View chapter
  3. Chapter 9 Service Type

    • Equipment Sales
    • Services And Aftermarket
    View chapter

Clinical Complexity and Workflow Integration Are Reshaping Veterinary Imaging

Veterinary imaging is moving from occasional diagnostic support toward a more integrated part of clinical pathways. Multimodal assessment is increasingly relevant for oncology, neurology, orthopedics, cardiology, dentistry, trauma, and soft-tissue disease. Practices are also prioritizing faster image transfer, structured reporting, teleradiology, interoperability with practice-management systems, and protocols that reduce repeat examinations. Adoption remains uneven because advanced modalities require capital, specialized operators, maintenance, sedation or anesthesia capabilities, and reliable referral networks.

Artificial Intelligence Is Improving Triage, Consistency, and Reporting Support

Artificial intelligence is being applied to image enhancement, anomaly detection, triage, segmentation, workflow prioritization, and reporting assistance. Its practical value is strongest when it supports-not replaces-veterinary judgment by helping clinicians identify urgent cases, compare studies, and standardize routine observations. Responsible deployment requires representative veterinary datasets, validation across species and breeds, transparent performance measures, cybersecurity, privacy controls, and clear accountability for false positives and missed findings. Integration with existing imaging and clinical systems will determine whether AI produces measurable workflow gains.

Regional Insights: Uneven Access Meets Broad Demand for Advanced Veterinary Care

North America benefits from established specialty practices, referral hospitals, advanced veterinary training, and comparatively broad access to high-end imaging, although affordability and workforce constraints remain important. Europe combines strong clinical infrastructure with varied reimbursement, regulatory, and procurement conditions across countries. Asia-Pacific contains highly developed markets alongside rapidly expanding urban veterinary services; workforce concentration and equipment access differ substantially between metropolitan and rural areas. Latin America is supported by growing companion-animal care but faces uneven investment, import dependence, and specialist availability. The Middle East shows concentrated demand around major urban and private healthcare hubs, while the African market is more heterogeneous, with access shaped by income, infrastructure, veterinary workforce distribution, and the relative importance of livestock versus companion-animal services.

Group Insights: Economic Blocs and Alliances Shape Adoption Conditions

ASEAN presents a diverse mix of veterinary infrastructure, urbanization, and regulatory environments, making partnerships, training, and service models important for access. BRICS economies combine large patient populations with substantial differences in purchasing power, domestic manufacturing, specialist capacity, and public-sector involvement. The European Union benefits from cross-border scientific and regulatory coordination, while implementation and reimbursement conditions still vary nationally. G7 countries generally have mature clinical ecosystems and strong research capacity, but face cost, labor, and equitable-access pressures. GCC markets are characterized by concentrated urban demand, investment in premium healthcare, and reliance on imported technology and expertise. NATO members span diverse veterinary systems; shared emphasis on resilience, cybersecurity, standards, and emergency preparedness can influence procurement and digital infrastructure priorities.

Country Insights: Capacity, Training, and Access Vary Across Major Markets

The United States and Canada have extensive specialty and referral capacity, with access moderated by geography, cost, and clinician availability. The United Kingdom, Germany, France, Italy, and Spain combine established veterinary education with differing reimbursement, procurement, and regional-access patterns. Australia has advanced urban veterinary services but faces distance-related access challenges. Japan and South Korea show technologically capable, urban-centered companion-animal care systems, while China is expanding veterinary services amid significant regional variation. India has a large and diverse animal-care landscape, with advanced imaging concentrated in leading urban institutions. Brazil and Mexico are supported by expanding companion-animal care but experience uneven equipment distribution and specialist access. Russia’s veterinary imaging capacity is shaped by urban concentration, supply conditions, and access to specialized training.

Priorities for Leaders: Build Scalable, Clinically Governed Imaging Services

Industry leaders should align modality investment with local caseloads, referral pathways, staffing, and total ownership costs rather than treating equipment acquisition as an isolated purchase. Scalable strategies include interoperable image archives, remote interpretation, technician training, preventive maintenance, standardized protocols, and partnerships with referral or teaching institutions. AI programs should begin with narrowly defined, clinically meaningful use cases and prospective validation, supported by governance for bias, auditability, cybersecurity, and human review. Providers should also improve client communication about diagnostic value, anesthesia or sedation, turnaround time, and total cost, while developing access models suited to rural and price-sensitive populations.

Research Methodology: Structured Assessment of Clinical, Technological, and Geographic Factors

This executive summary uses a qualitative framework for assessing pet diagnostic imaging across modalities, care settings, technologies, and geographies. The analysis considers documented developments in veterinary practice, equipment and workflow requirements, digital-image management, AI applications, clinical specialization, workforce capacity, infrastructure, regulation, and affordability. Regional, group, and country comparisons are presented as contextual interpretations rather than quantified rankings. No market estimates, market shares, forecasts, or company-specific claims are included; conclusions should be supplemented with current primary research and local regulatory and clinical evidence before investment decisions.

Conclusion: Better Integration Can Expand the Clinical Value of Pet Imaging

Pet diagnostic imaging is becoming more central to timely, evidence-informed veterinary care, but progress depends on more than advanced hardware. Sustainable adoption requires trained personnel, interoperable workflows, reliable interpretation, appropriate clinical governance, and access models that reflect local conditions. AI can strengthen efficiency and consistency when rigorously validated and embedded within accountable care pathways. Leaders that combine clinical usefulness, operational resilience, workforce development, and responsible digital integration will be best positioned to improve diagnostic quality across diverse veterinary systems.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Pet Diagnostic Imaging Market, by Imaging Modality
    1. 7.1Introduction
    2. 7.2Radiography Systems
      1. 7.2.1Conventional Radiography
      2. 7.2.2Computed Radiography
      3. 7.2.3Direct Digital Radiography
    3. 7.3Ultrasound Systems
      1. 7.3.1Cart-based Ultrasound
        1. 7.3.1.12D Ultrasound
        2. 7.3.1.23D and 4D Ultrasound
        3. 7.3.1.3Doppler Ultrasound
      2. 7.3.2Portable Ultrasound
        1. 7.3.2.1Handheld Ultrasound
        2. 7.3.2.2Laptop-based Ultrasound
    4. 7.4Computed Tomography Systems
      1. 7.4.1Single-slice CT
      2. 7.4.2Multi-slice CT
      3. 7.4.3Cone Beam CT
    5. 7.5Magnetic Resonance Imaging Systems
      1. 7.5.1Low-field MRI
      2. 7.5.2High-field MRI
    6. 7.6Nuclear Imaging Systems
      1. 7.6.1Positron Emission Tomography
      2. 7.6.2Single Photon Emission Computed Tomography
      3. 7.6.3Hybrid PET or CT Systems
      4. 7.6.4Hybrid SPECT or CT Systems
    7. 7.7Fluoroscopy Systems
    8. 7.8Dental Imaging Systems
      1. 7.8.1Intraoral Dental Imaging
      2. 7.8.2Extraoral Dental Imaging
  8. 8.Pet Diagnostic Imaging Market, by Animal Type
    1. 8.1Introduction
    2. 8.2Cats
    3. 8.3Dogs
    4. 8.4Equine
    5. 8.5Laboratory Animals
  9. 9.Pet Diagnostic Imaging Market, by Service Type
    1. 9.1Introduction
    2. 9.2Equipment Sales
      1. 9.2.1New Equipment
      2. 9.2.2Refurbished Equipment
    3. 9.3Services And Aftermarket
      1. 9.3.1Calibration And Training
      2. 9.3.2Maintenance
  10. 10.Pet Diagnostic Imaging Market, by End User
    1. 10.1Introduction
    2. 10.2Academic Institutes
    3. 10.3Diagnostic Laboratories
    4. 10.4Research Institutes
    5. 10.5Specialty Hospitals
    6. 10.6Veterinary Clinics
  11. 11.Pet Diagnostic Imaging Market, by Region
    1. 11.1Introduction
    2. 11.2Asia-Pacific
    3. 11.3North America
    4. 11.4Latin America
    5. 11.5Europe
    6. 11.6Middle East
    7. 11.7Africa
  12. 12.Pet Diagnostic Imaging Market, by Group
    1. 12.1Introduction
    2. 12.2ASEAN
    3. 12.3GCC
    4. 12.4European Union
    5. 12.5BRICS
    6. 12.6G7
    7. 12.7NATO
  13. 13.Pet Diagnostic Imaging Market, by Country
    1. 13.1Introduction
    2. 13.2United States
    3. 13.3Canada
    4. 13.4Mexico
    5. 13.5Brazil
    6. 13.6United Kingdom
    7. 13.7Germany
    8. 13.8France
    9. 13.9Russia
    10. 13.10Italy
    11. 13.11Spain
    12. 13.12China
    13. 13.13India
    14. 13.14Japan
    15. 13.15Australia
    16. 13.16South Korea
  14. 14.Competitive Landscape
    1. 14.1Market Share Analysis, 2025
    2. 14.2Market Concentration Analysis, 2025
      1. 14.2.1Concentration Ratio (CR)
      2. 14.2.2Herfindahl Hirschman Index (HHI)
    3. 14.3Recent Developments & Impact Analysis, 2025
    4. 14.4Product Portfolio Analysis, 2025
    5. 14.5Benchmarking Analysis, 2025
  15. 15.Company Profiles
    1. 15.1Agfa‑Gevaert Group
    2. 15.2Allied Healthcare Products, Inc.
    3. 15.3Antech Imaging Services
    4. 15.4Bruker Corporation
    5. 15.5Canon Medical Systems Corporation
    6. 15.6CareFusion
    7. 15.7Carestream Health, Inc.
    8. 15.8Esaote SpA
    9. 15.9FUJIFILM Holdings Corporation
    10. 15.10GE Healthcare
    11. 15.11Hoya Corporation
    12. 15.12IDEXX Laboratories, Inc.
    13. 15.13IMV Imaging
    14. 15.14Konica Minolta, Inc.
    15. 15.15Koninklijke Philips N.V.
    16. 15.16Medtronic plc
    17. 15.17Nikon Corporation
    18. 15.18Olympus Corporation
    19. 15.19Samsung Medison Co., Ltd.
    20. 15.20Siemens Healthineers AG
    21. 15.21Sound Technologies, LLC
    22. 15.22Summus Medical Laser, Inc.
    23. 15.23VCA Inc.
    24. 15.24VetCT Group Ltd.
    25. 15.25Vetel Diagnostics Ltd.
  16. 16.Key Experts

Loading the sample request form…